Thus, hyperinsulinaemia may further accentuate the progression of renal disease in states of insulin resistance, including diabetic nephropathy, and the maintenance of podocyte nephrin and IR expression and function in these settings may be therapeutically beneficial. The gene discussed is NPHS1; the disease is diabetic kidney disease.